Forgot your password?
Haven't registered yet?
12/3/2014CMSC INforMS: First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval
12/3/2014CMSC Press Release: CMSC Announces A Virtual Support Group for Multiple Sclerosis Patients
11/14/2014CMSC INforMS: Genzyme’s Lemtrada Approved by the FDA
11/4/2014CMSC INforMS: Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in RRMS
10/31/2014CMSC Press Release: Study on Abnormal MRIs and the Risk of Developing MS Featured in the IJMSC
2/12/2014 » 2/12/2015Individualized Learning Plan: Confronting Current Challenges in Multiple Sclerosis Treatment